A team at the University of Illinois Chicago has now introduced an imaging strategy designed to reveal previously obscured enzyme activity across the entire live cell. The work, published in the Proceedings of the National Academy of Sciences, enables scientists to map where specific biochemical events happen with higher clarity and spatial resolution.

The core challenge lies in biosensors that report negatively: instead of glowing when an enzyme is active, they “go dark” when activity changes. Those dim signals can blend into background regions during imaging, creating false ambiguity—areas with real high activity can appear similar to areas with little or none.

The researchers developed a method called Fluctuation Increase Negated by Intra-Chain (FINICI). FINICI converts the inverted readout of negative biosensors into a positive, interpretable optical signal. By effectively flipping the sensor logic, the approach allows existing negative biosensors to be used without years of redesign.

Using FINICI, the team imaged three targets: Src kinase, Syk kinase, and cGMP. For Src kinase, they observed burst-like activity concentrated in small regions of the cell membrane, including cholesterol-rich lipid rafts. Some active nanodomains appeared only briefly, while others persisted—kinetics that would be blurred out by whole-cell measurements.

For cGMP, the imaging revealed that the molecule forms small clusters that rapidly become overwhelmed as the signal spreads outward through the cell.

In immune cells, Syk kinase showed the opposite of a simplistic “near the receptor” picture: activity was most prominent near internal scaffolding rather than at the sites where upstream receptors are triggered. This spatial mismatch suggests that signaling outcomes depend strongly on subcellular positioning.

Overall, the study supports the idea that enzyme activity is location-dependent: being active is not enough if the enzyme is not in the right compartment. The implications extend to drug development, where therapeutic success often hinges on where drug targets and their signaling partners meet inside cells.

Subject of Research: Live cell enzyme activity imaging using inverse (negative) biosensors
Article Title: Directly adopting inverse biosensors to image live cell enzyme activities in nanodomains
News Publication Date:
Web References: https://www.pnas.org/doi/10.1073/pnas.2531118123
References:
Image Credits: Credit: Gary Mo.

Keywords: Biosensors, imaging, live cells, enzyme activity, nanodomains, FINICI, signal transduction, kinase signaling, cGMP

Fluorescent biosensors have been invaluable tools in biomedical research due to their ability to provide direct, live-cell readouts of signaling activities such as phosphorylation events mediated by kinases. Yet, conventional fluorescent proteins and dyes exhibit limitations in resolution, photostability, and spectral overlap, restricting their utility particularly when attempting to resolve nanoscopic signaling domains or multiplex several signaling molecules in tandem. Recognizing these constraints, the research team sought to create biosensors that transcend these barriers by harnessing the modularity of chemigenetic approaches. Their design centers on the HaloTag7 system, a genetically encoded self-labeling tag that covalently binds synthetic ligands, allowing precise incorporation of tailor-made fluorophores optimized for far-red emission characteristics.

Far-red synthesis fluorophores offer multiple advantages, including reduced phototoxicity, enhanced tissue penetration, and minimal autofluorescence interference, which collectively improve live-cell imaging fidelity. When conjoined with HaloTag7-modified kinase biosensors, these synthetic probes empower researchers to perform four-dimensional imaging—capturing x, y, z spatial information alongside time dynamics—with heightened sensitivity. The application of far-red emitting fluorophores also opens compatibility with advanced super-resolution microscopy methods such as stimulated emission depletion (STED) microscopy, which circumvents the diffraction limit that traditionally plagues optical microscopy. By leveraging STED, the investigators successfully visualized protein kinase A (PKA) signaling activity localized to individual clathrin-coated pits, revealing previously inaccessible nanoscale signaling events integral to cellular trafficking and signal transduction.

One of the most transformative aspects of this technology lies in its multiplexing capacity. The researchers demonstrated simultaneous imaging of up to five distinct analytes within single living cells—a dramatic increase over conventional techniques. This enhanced dimensionality is achieved through the strategic selection of spectrally separable synthetic fluorophores and orthogonal kinase biosensor designs, enabling precise tracking of multiple signaling events in parallel. This multiplexed imaging capability provides unprecedented insights into how numerous signaling pathways intersect, coordinate, and modulate cellular responses in real time, a feat crucial for unraveling the complex orchestration underpinning cellular decision-making processes.

The team further showcased the utility of their biosensor platform by probing the cellular responses elicited by activation of diverse G-protein-coupled receptors (GPCRs), a large and pharmaceutically important family of membrane receptors. By selectively stimulating individual GPCR–ligand pairs, they quantitatively dissected the resultant spatiotemporal network states of downstream signaling, elucidating distinct signaling signatures within living cells. This level of interrogation affords a granular view of how different receptors bias signaling cascades and influence cellular phenotypes, offering valuable insights for drug discovery and precision medicine initiatives targeting GPCR-mediated pathways.

In developing the chemigenetic kinase biosensors, careful biochemical engineering was necessary to preserve the catalytic activity and targeting specificity of kinase sensing domains while enabling modular attachment of far-red fluorophores. HaloTag7’s covalent labeling chemistry ensures stoichiometric and site-specific attachment, critical for quantitative imaging. The fluorophores were judiciously chosen to optimize brightness, photostability, and compatibility with cellular imaging conditions, ensuring that the biosensors retain high signal-to-noise in physiological environments and during prolonged observation periods.

The researchers validated the performance of their biosensors in diverse cellular models, confirming robust kinase activity readouts with high spatial resolution. The application of STED microscopy revealed clustering and dynamics of PKA activity at sub-diffraction spatial scales, offering compelling evidence that localized kinase signaling events orchestrate precise cellular functions. Such nanoscale visualization was previously unattainable, highlighting the transformative potential of combining chemigenetic approaches with super-resolution imaging modalities.

This breakthrough also opens avenues for dynamic interrogation of intracellular signaling networks under physiological and pathological conditions. The real-time activity mapping of multiple kinases simultaneously enables detailed reconstruction of signaling crosstalk and feedback loops. This ability may drive forward research into cancer biology, neurodegenerative disorders, and immunology, where aberrant phosphorylation and signaling regulation play pivotal roles.

Importantly, the far-red chemigenetic biosensor technology is versatile and customizable, allowing adaptation to a broad range of kinases and signaling molecules beyond PKA. The modular platform can potentially be extended to monitor other enzymatic activities or post-translational modifications, enhancing its utility as a general toolkit for studying cell signaling with super-resolution precision.

Besides applications in fundamental research, this innovation holds promise for translational and clinical research contexts, where understanding signaling heterogeneity at the single-cell level informs therapeutic strategies. Multiplexed detection directly in living cells facilitates more accurate phenotyping, high-throughput screening, and pharmacodynamic assessment, advancing personalized medicine approaches.

The study underscores the synergistic power of combining genetically encoded biosensors with synthetic fluorophore chemistry and cutting-edge microscopy to illuminate cellular processes in ways previously inconceivable. By breaking through historic constraints on resolution and multiplexing, researchers gain an unprecedented window into the spatiotemporal complexity of signaling networks.

Looking ahead, continual refinement of fluorophore chemistries, probe engineering, and imaging techniques will likely expand the capabilities of chemigenetic biosensors. Integration with complementary methods such as optogenetics, single-molecule tracking, and machine learning-driven image analysis could further deepen insights into cell biology, driving discovery and innovation.

Overall, the far-red chemigenetic kinase activity biosensors represent a major leap forward in our ability to visualize and quantify molecular signaling dynamics within living cells. By enabling simultaneous multiplexed and super-resolved imaging, this technology offers a powerful new lens to decipher the complexities of cellular signaling networks critical to health and disease.

Subject of Research: Development of far-red chemigenetic kinase biosensors for multiplexed and super-resolution imaging of cellular signaling networks.

Article Title: Far-red chemigenetic kinase biosensors enable multiplexed and super-resolved imaging of signaling networks.

Article References:
Frei, M.S., Sanchez, S.A., He, X. et al. Far-red chemigenetic kinase biosensors enable multiplexed and super-resolved imaging of signaling networks. Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02642-8

Image Credits: AI Generated